Oncology
19810 items found
News
Vydura is first NICE-backed oral GPCR for acute migraine
Pfizer's Vydura has become the first drug in the oral GPCR receptor …
Sales & Marketing
Sponsored
12 Questions with Stefan Woxström
Stefan Woxström leads the Europe and Canada business at AstraZeneca …
News
Oral phenylephrine vote may see OTC products pulled in US
An FDA advisory committee has concluded that a commonly used …
News
EU clears review of Xtandi in earlier-stage prostate cancer
The EMA will kick off a review of Astellas and Pfizer's prostate …
News
Leschly steps down as 2seventy wields the axe
2seventy bio is slashing 40% of its workforce to conserve cash as it …
Digital
Revolutionising life sciences with AI and automation: An enterprise modernisation journey
The life sciences industry is embracing the transformative power of …
Home
Pitango partner talks new $175M health tech fund, AI, and rocky markets
Last week, Israel’s Pitango VC announced the closing of its second …
News
Clinigen launches scheme to support rare disease patients
Clinigen has launched a new programme in the UK that aims to help …
News
Fresh from IPO, Acelyrin's lead drug fails clinical trial
Acelyrin has been flying high in the wake of an unusually large …
News
Eisai launches digital dementia specialist company
Eisai has been steadily building up expertise in the use of digital …
News
Novartis drops geographic atrophy gene therapy
Novartis has confirmed it will discontinue development of a gene …
R&D
Partner Content
Welcome to the Molecular Glue Drug Development Summit!
The Molecular Glue Drug Development Summit is back in January, 2025!
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Welcome to the 6th RNAi-Based Therapeutics Summit!
RNAi-Based Therapeutics Returns!
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
